Zymergen pulls in $130 mln Series B
Emeryville, California-based Zymergen, a tech company that is "unlocking the power of biology," has secured $130 million in Series B funding. SoftBank Group led the round with participation from Data Collective, True Ventures, AME Cloud Ventures, DFJ, Innovation Endeavors, Obvious Ventures, Two Sigma Ventures, Iconiq Capital, Prelude Ventures and Tao Capital Partners. Also, the company has named former U.S. Secretary of Energy and Nobel laureate Dr. Steven Chu and SoftBank Group International Managing Director Deep Nishar to its board of directors.
11 October 2016•1 min read
